WallStreetZenWallStreetZen

NASDAQ: SPTX
Seaport Therapeutics Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Seaport Therapeutics earnings were -$74.9M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest SPTX earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SPTX reported annual earnings of -$74.9M, with 59.7% growth.

SPTX earnings history

Current Revenue
$0.0
Current Earnings
-$74.9M
Current Profit Margin
0%

SPTX Return on Equity

Insufficient data to display

SPTX Return on Assets

Current Company
-26.5%
Current Industry
-9.6%

Be the first to know when SPTX announces earnings.

SPTX Return on Capital Employed

Current Company
-31.37%
Current Industry
-3.7%

SPTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ACHV-$53.60M-$54.65MN/A-$1.25
AAPG-$160.60M-$182.22MN/A-$2.05
AARD-$57.18M-$57.59MN/A-$2.93
ABUS-$33.04M-$33.50MN/A-$0.17
ABVX-$249.93M-$386.32MN/A-$5.55
View Top Biotech Stocks

Seaport Therapeutics Earnings Reports & History FAQ

What were Seaport Therapeutics's earnings last quarter?

Seaport Therapeutics (NASDAQ: SPTX) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total SPTX earnings for the quarter were N/A. In the same quarter last year, Seaport Therapeutics's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Seaport Therapeutics stock.

Is Seaport Therapeutics profitable or losing money?

As of the last Seaport Therapeutics earnings report, Seaport Therapeutics is currently losing money. Seaport Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$74.88 million, a 59.73% increase year over year.

What was SPTX's earnings growth in the past year?

As of Seaport Therapeutics's earnings date in Q2 2026, Seaport Therapeutics's earnings has grown year over year. SPTX earnings in the past year totalled -$74.88 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.